William Blair & Company’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$340K Buy
+730
New +$307K ﹤0.01% 1365
2024
Q4
Sell
-2,468
Closed -$1.48M 1827
2024
Q3
$1.48M Sell
2,468
-8
-0.3% -$4.54K ﹤0.01% 796
2024
Q2
$1.34M Buy
2,476
+76
+3% +$43.5K ﹤0.01% 790
2024
Q1
$1.54M Sell
2,400
-12
-0.5% -$7.29K ﹤0.01% 750
2023
Q4
$1.41M Sell
2,412
-62
-3% -$34.7K ﹤0.01% 757
2023
Q3
$1.29M Sell
2,474
-147
-6% -$76.4K ﹤0.01% 765
2023
Q2
$1.42M Hold
2,621
0.01% 744
2023
Q1
$1.41M Buy
2,621
+612
+30% +$312K 0.01% 742
2022
Q4
$1.03M Buy
2,009
+26
+1% +$12.7K ﹤0.01% 816
2022
Q3
$866K Buy
1,983
+573
+41% +$276K ﹤0.01% 862
2022
Q2
$662K Sell
1,410
-33
-2% -$16.1K ﹤0.01% 977
2022
Q1
$731K Sell
1,443
-51
-3% -$24.5K ﹤0.01% 1028
2021
Q4
$790K Buy
1,494
+310
+26% +$149K ﹤0.01% 1038
2021
Q3
$551K Buy
+1,184
New +$558K ﹤0.01% 1123

Other funds holding CHE

William Blair & Company's CHE Position: Q2 2026 in Review

William Blair & Company opened a new position in Chemed (CHE) in Q2 2026: 730 shares worth $340K. The stake represents ﹤0.01% of the portfolio and ranks #1365 among its holdings. This is a return to the name: William Blair & Company previously reported a position in CHE as recently as Q3 2024.

William Blair & Company first reported a position in CHE in Q3 2021 and has held it in 14 quarters since. The position peaked at $1.54M in Q1 2024. 532 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • William Blair & Company held 730 shares of Chemed worth $340K as of Q2 2026.
  • Chemed was a new William Blair & Company position in Q2 2026.
  • Chemed made up ﹤0.01% of William Blair & Company's portfolio in Q2 2026, its #1365 holding.
  • William Blair & Company first reported a position in Chemed in Q3 2021 and has held it in 14 quarters since.
  • William Blair & Company's Chemed position peaked at $1.54M in Q1 2024.
  • 532 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on William Blair & Company's 13F filing for Q2 2026, filed 11 Aug 2026.